Executive Summary: Global Value-Based Care Enablement Market

2.1. Research Objective

2.2. Product Overview

2.3. Market Segmentation

2.4. Qualitative Research
2.4.1. Primary & Secondary Sources

2.5. Quantitative Research
2.5.1. Primary & Secondary Sources

2.6. Breakdown of Primary Research Respondents, By Region

2.7. Assumption for Study

2.8. Market Size Estimation

2.9. Data Triangulation

3.1. Industry Value Chain Analysis
3.1.1. Health Data & Interoperability Providers
3.1.2. Population Health & Analytics Platform Developers
3.1.3. Risk Adjustment, Coding & Reporting Solution Providers
3.1.4. Care Management & Enablement Service Providers
3.1.5. Payers & Risk-Bearing Entities
3.1.6. Provider Organisations & Patients (End Users)

3.2. Industry Outlook
3.2.1. Overview of the Global Value-Based Care & Risk-Bearing Enablement Landscape
3.2.2. Shift from Fee-for-Service to Capitation and Shared-Risk Models

3.3. PESTLE Analysis

3.4. Porter's Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitutes
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition

3.5. Market Growth and Outlook
3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
3.5.2. Price Trend Analysis, By Offering

4.1. Competition Dashboard
4.1.1. Market Concentration Rate
4.1.2. Company Market Share Analysis (Value %), 2025
4.1.3. Competitor Mapping & Benchmarking

5.1. Market Dynamics and Trends
5.1.1. Growth Drivers
5.1.2. Restraints
5.1.3. Opportunity
5.1.4. Key Trends

5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
5.2.1. By Offering
5.2.1.1. Key Insights
5.2.1.1.1. Population Health Platforms
5.2.1.1.2. Risk Adjustment & Coding
5.2.1.1.3. Care Management & Coordination
5.2.1.1.4. Quality & Regulatory Reporting
5.2.1.1.5. Network & Contract Analytics
5.2.1.1.6. Managed Enablement Services
5.2.2. By Payment Model
5.2.2.1. Key Insights
5.2.2.1.1. Shared Savings
5.2.2.1.2. Bundled Payments
5.2.2.1.3. Full Capitation
5.2.2.1.4. Partial Risk
5.2.3. By Provider Type
5.2.3.1. Key Insights
5.2.3.1.1. Primary Care Groups
5.2.3.1.2. Specialty Practices
5.2.3.1.3. Health Systems
5.2.3.1.4. Federally Qualified Health Centers
5.2.4. By Payer Channel
5.2.4.1. Key Insights
5.2.4.1.1. Medicare Advantage
5.2.4.1.2. Traditional Medicare (ACO)
5.2.4.1.3. Medicaid
5.2.4.1.4. Commercial
5.2.5. By Region
5.2.5.1. Key Insights
5.2.5.1.1. North America
5.2.5.1.1.1. The U.S.
5.2.5.1.1.2. Canada
5.2.5.1.1.3. Mexico
5.2.5.1.2. Europe
5.2.5.1.2.1. Western Europe
5.2.5.1.2.1.1. The UK
5.2.5.1.2.1.2. Germany
5.2.5.1.2.1.3. France
5.2.5.1.2.1.4. Italy
5.2.5.1.2.1.5. Spain
5.2.5.1.2.1.6. Rest of Western Europe
5.2.5.1.2.2. Eastern Europe
5.2.5.1.2.2.1. Poland
5.2.5.1.2.2.2. Russia
5.2.5.1.2.2.3. Rest of Eastern Europe
5.2.5.1.3. Asia Pacific
5.2.5.1.3.1. China
5.2.5.1.3.2. India
5.2.5.1.3.3. Japan
5.2.5.1.3.4. Australia & New Zealand
5.2.5.1.3.5. South Korea
5.2.5.1.3.6. ASEAN
5.2.5.1.3.7. Rest of Asia Pacific
5.2.5.1.4. Middle East & Africa
5.2.5.1.4.1. Saudi Arabia
5.2.5.1.4.2. South Africa
5.2.5.1.4.3. UAE
5.2.5.1.4.4. Rest of MEA
5.2.5.1.5. South America
5.2.5.1.5.1. Argentina
5.2.5.1.5.2. Brazil
5.2.5.1.5.3. Rest of South America

6.1. Market Dynamics and Trends
6.1.1. Growth Drivers
6.1.2. Restraints
6.1.3. Opportunity
6.1.4. Key Trends

6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
6.2.1. Key Insights
6.2.1.1. By Offering
6.2.1.2. By Payment Model
6.2.1.3. By Provider Type
6.2.1.4. By Payer Channel
6.2.1.5. By Country

7.1. Market Dynamics and Trends
7.1.1. Growth Drivers
7.1.2. Restraints
7.1.3. Opportunity
7.1.4. Key Trends

7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
7.2.1. Key Insights
7.2.1.1. By Offering
7.2.1.2. By Payment Model
7.2.1.3. By Provider Type
7.2.1.4. By Payer Channel
7.2.1.5. By Country

8.1. Market Dynamics and Trends
8.1.1. Growth Drivers
8.1.2. Restraints
8.1.3. Opportunity
8.1.4. Key Trends

8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
8.2.1. Key Insights
8.2.1.1. By Offering
8.2.1.2. By Payment Model
8.2.1.3. By Provider Type
8.2.1.4. By Payer Channel
8.2.1.5. By Country

9.1. Market Dynamics and Trends
9.1.1. Growth Drivers
9.1.2. Restraints
9.1.3. Opportunity
9.1.4. Key Trends

9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
9.2.1. Key Insights
9.2.1.1. By Offering
9.2.1.2. By Payment Model
9.2.1.3. By Provider Type
9.2.1.4. By Payer Channel
9.2.1.5. By Country

10.1. Market Dynamics and Trends
10.1.1. Growth Drivers
10.1.2. Restraints
10.1.3. Opportunity
10.1.4. Key Trends

10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
10.2.1. Key Insights
10.2.1.1. By Offering
10.2.1.2. By Payment Model
10.2.1.3. By Provider Type
10.2.1.4. By Payer Channel
10.2.1.5. By Country

11.1. Privia Health
11.2. agilon health
11.3. Evolent Health
11.4. Innovaccer
11.5. Arcadia
11.6. Health Catalyst
11.7. Optum
11.8. Elevance (CarelonRx)
11.9. Aledade
11.10. Pearl Health
11.11. Milliman MedInsight
11.12. Cotiviti
11.13. Signify Health (CVS)
11.14. Clarify Health
11.15. Lumeris
11.16. Other Prominent Players

12.1. List of Secondary Sources
12.2. Key Country Markets- Macro Economic Outlook/Indicators